Form 4: Columbia Financial Executive Jenifer White Walden Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Executive Vice President and CHRO of Columbia Financial, Jenifer White Walden, reports acquisition of common stock and holdings of stock options and awards.

Summary

  • Jenifer White Walden, an Executive Vice President and CHRO at Columbia Financial, Inc., reported several transactions related to the company's stock.
  • On December 13, 2024, she acquired 33.4725 shares of common stock at $16.93 per share through a stock-based deferral plan.
  • She also holds various common stock units through different plans including 1,832.1455 through a stock-based deferral plan, 2,008 directly, 982 through an ESOP, 45 through a SERP, 14 through a SIM, 649 through a stock award, 7,817 through a stock award II, and 7,597 through a stock award III.
  • Additionally, she holds stock options to purchase 5,540 shares at $20.54, 6,203 shares at $15.94, and 5,107 shares at $16.49, all of which vest over time.

Sentiment

Score: 7

Explanation: The document is a routine disclosure of stock transactions, which is neither positive nor negative in itself. The sentiment is neutral to slightly positive due to the executive's continued investment in the company.

Positives

  • The acquisition of shares through the stock-based deferral plan indicates continued investment in the company by the executive.
  • The vesting of stock options and awards aligns the executive's interests with the long-term performance of the company.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in the financial industry.

Comparison to Industry Standards

  • Stock-based compensation and deferral plans are standard practice for executive compensation in publicly traded companies like Columbia Financial.
  • The vesting schedules for stock options and awards are typical, often spanning three to four years to incentivize long-term performance.
  • The use of ESOPs, SERPs, and SIMs are common methods for providing retirement and deferred compensation benefits to employees and executives.

Stakeholder Impact

  • The stock transactions may have a minor impact on shareholders, as they reflect the executive's holdings and alignment with the company's performance.
  • The vesting of stock options and awards may incentivize the executive to work towards the company's long-term success.

Key Dates

DateDescription
10/31/2023Commencement of vesting for stock options with an exercise price of $20.54.
05/01/2024Commencement of vesting for stock options with an exercise price of $15.94 and stock awards II.
12/13/2024Date of common stock acquisition through the stock-based deferral plan.
03/06/2025Commencement of vesting for stock options with an exercise price of $16.49 and stock awards III.
10/31/2032Expiration date for stock options with an exercise price of $20.54.
05/01/2033Expiration date for stock options with an exercise price of $15.94.
03/06/2034Expiration date for stock options with an exercise price of $16.49.
12/17/2024Date of signature for the report.

Keywords

stock, equity, options, shares, insider trading, executive compensation, stock awards, stock-based deferral plan, ESOP, SERP, SIM, vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.